Prof. Tariq Abbas

Main Areas of Expertise

• Bioinformatics
• Genomics
• Pharmacogenomics
• Personalized medicine
• GPCR biology and pharmacology
• Molecular signaling
• Computational structural biology
• Molecular dynamics / computational modeling
• Metabolic receptors and incretin biology
• Drug response and adverse drug reactions
• Translational biomedical research

Selected Publications

1. “Type-1 Cannabinoid Receptor Promiscuous Coupling: Computational Insights into Receptor-G Protein Interaction Dynamics” — International Journal of Molecular Sciences, 2025.
2. “G protein-coupled receptor (GPCR) pharmacogenomics” — Critical Reviews in Clinical Laboratory Sciences, 2024.
3. “Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes” — Nature Metabolism, 2024.
4. “GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics” — Nature Communications, 2023.
5. “Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation” — International Journal of Molecular Sciences, 2023 listing.

Conference Involvement

Berghella is currently listed as a speaker at the 2nd International Symposium on Hypospadias: From Foundations to Frontiers, taking place 9–10 December 2026 at Sidra Medicine, Doha, Qatar. The official Sidra Medicine event page lists him among the speakers, alongside pediatric urology and pediatric surgery specialists from Qatar and internationally.

This is notable because his role at the meeting appears to be research/scientific rather than clinical surgical practice; Sidra identifies him as a PhD Staff Scientist, while the symposium itself covers pediatric urology, pediatric surgery and hypospadias.

Important identity note: There is also Vincenzo Berghella, MD, a completely different physician specializing in maternal-fetal medicine at Thomas Jefferson University. I have kept the two profiles separate here.